Condition: Rotator Cuff Arthropathy · Sponsor: University of Aarhus
Reverse shoulder arthroplasty (RSA) is a well-established treatment for rotator cuff arthropathy. However, the effectiveness of RSA has not been compared to non-surgical treatment in a randomised controlled trial. Shoulder exercises may be an effective treatment for reducing pain and improving function in glenohumeral osteoarthritis. The primary aim of this trial is to examine if RSA followed by standard postsurgical rehabilitation is superior to a 12-week exercise programme in patients with rotator cuff arthropathy eligible for unilateral RSA. The investigators hypothesise that surgical intervention followed by standard rehabilitation, results in clinically relevant (14-point, on a scale from 0-100) improvement compared to the exercise intervention.
This description comes directly from the study's public registry record.
Josefine B. Larsen, MSc · 4526237771 · josefinebl@clin.au.dk
Inger Mechlenburg, Prof. · 4521679062 · inger.mechlenburg@clin.au.dk
Always discuss trial participation with your own doctor first.
| Aarhus University Hospital | Aarhus N, Denmark | Recruiting |
| Esbjerg Hospital | Esbjerg, Denmark | Recruiting |
| Aalborg University Hospital | Farsø, Denmark | Recruiting |
| Silkeborg Regional Hospital | Silkeborg, Denmark | Recruiting |
| Viborg Regional Hospital | Viborg, Denmark | Recruiting |
| Tartu University Hospital | Tartu, Estonia | Recruiting |
| Tampere University Hospital | Tampere, Finland | Recruiting |
| Oslo University Hospital | Oslo, Norway | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04864158